Overview

A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy

Status:
Terminated
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
Evaluate the clinical efficacy and safety of droxidopa versus placebo over a 17 week (maximum) treatment period in patients with symptomatic NOH.
Phase:
Phase 3
Details
Lead Sponsor:
Chelsea Therapeutics
Treatments:
Droxidopa
Mannitol